High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema.

[1]  J. Bronzwaer,et al.  Myocardial contractile effects of nitric oxide. , 2002 .

[2]  J. Masip,et al.  Non-invasive pressure support ventilation versus conventional oxygen therapy in acute cardiogenic pulmonary oedema: a randomised trial , 2000, The Lancet.

[3]  P. Mcdermott,et al.  Effect of ED management on ICU use in acute pulmonary edema. , 1999, The American journal of emergency medicine.

[4]  T. Welte,et al.  The use of noninvasive pressure support ventilation for severe respiratory insufficiency due to pulmonary oedema , 1999, Intensive Care Medicine.

[5]  S. Gayol,et al.  Noninvasive pressure support ventilation (NIPSV) with face mask in patients with acute cardiogenic pulmonary edema (ACPE) , 1999, Intensive Care Medicine.

[6]  S. Keenan,et al.  The effect of positive pressure airway support on mortality and the need for intubation in cardiogenic pulmonary edema: a systematic review. , 1998, Chest.

[7]  A. Sakamoto,et al.  Effect of nasal continuous positive airway pressure on pulmonary edema complicating acute myocardial infarction. , 1998, Japanese circulation journal.

[8]  Y. Moshkovitz,et al.  Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema , 1998, The Lancet.

[9]  M. L. Sica,et al.  Intravenous nitrates in the prehospital management of acute pulmonary edema. , 1997, Annals of emergency medicine.

[10]  G. Jay,et al.  Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema. , 1997, Critical care medicine.

[11]  B. Lüderitz,et al.  N-acetylcysteine attenuates nitroglycerin tolerance in patients with angina pectoris and normal left ventricular function. , 1997, The American journal of cardiology.

[12]  D. Northridge,et al.  Frusemide or nitrates for acute heart failure? , 1996, The Lancet.

[13]  J. Floras,et al.  Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. , 1995, Circulation.

[14]  W. Hsueh,et al.  Potentiation of isosorbide dinitrate effects with N-acetylcysteine in patients with chronic heart failure. , 1994, Circulation.

[15]  F. Russel,et al.  Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance , 1994, Journal of internal medicine.

[16]  A. Dimarco,et al.  Respiratory muscle rest using nasal BiPAP ventilation in patients with stable severe COPD. , 1994, Chest.

[17]  J Ludbrook,et al.  Repeated measurements and multiple comparisons in cardiovascular research. , 1994, Cardiovascular research.

[18]  M. Lee,et al.  Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of bumetanide , 1986, Biopharmaceutics & drug disposition.

[19]  D. Hartmann,et al.  Two-site direct immunoassay specific for active renin. , 1992, Clinical chemistry.

[20]  M. Lahav,et al.  Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. , 1992, Chest.

[21]  G. Sutton,et al.  Heart Failure in a District General Hospital , 1992, Journal of the Royal College of Physicians of London.

[22]  F. Russel,et al.  Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers , 1992, Clinical pharmacology and therapeutics.

[23]  N. Kissoon,et al.  Comparison of continuous versus intermittent furosemide administration in postoperative pediatric cardiac patients , 1992, Critical care medicine.

[24]  A D Bersten,et al.  Treatment of severe cardiogenic pulmonary edema with continuous positive airway pressure delivered by face mask. , 1991, The New England journal of medicine.

[25]  J. Horowitz,et al.  Acute heart failure: determinants of outcome. , 1991, International journal of cardiology.

[26]  D. Brater,et al.  Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy. , 1991, Annals of internal medicine.

[27]  J. Puschett,et al.  Acid-base disturbances in cardiogenic pulmonary edema. , 1991, Nephron.

[28]  J. Magovern,et al.  Diuresis in hemodynamically compromised patients: continuous furosemide infusion. , 1990, The Annals of thoracic surgery.

[29]  A. Tarral,et al.  Acute pulmonary oedema: preliminary results of a randomized trial of the intravenous phosphodiesterase inhibitor, enoximone, vs conventional therapy. , 1990, International journal of cardiology.

[30]  A. J. Man in 't Veld,et al.  Determination of catecholamines in human plasma by high-performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. , 1989, Journal of chromatography.

[31]  F. Russel,et al.  Solid-phase extraction of furosemide from plasma and urine and subsequent analysis by high-performance liquid chromatography. , 1989, Journal of chromatography.

[32]  R. Fish,et al.  Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris. , 1988, Circulation.

[33]  C. Harf,et al.  Emergency treatment of severe cardiogenic pulmonary edema with intravenous isosorbide-5-mononitrate. , 1988, The American journal of cardiology.

[34]  P. Gerlag,et al.  High-dose furosemide in the treatment of refractory congestive heart failure. , 1988, Archives of internal medicine.

[35]  Amber Denomme,et al.  Pulmonary edema. , 1988, Journal of thoracic imaging.

[36]  P. Chouraqui,et al.  Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology. , 1988, European heart journal.

[37]  J. Hoffman,et al.  Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema. , 1987, Chest.

[38]  S. Gottlieb,et al.  Prevention and reversal of nitrate tolerance in patients with congestive heart failure. , 1987, The New England journal of medicine.

[39]  J. Räsänen,et al.  Continuous positive airway pressure and supplemental oxygen in the treatment of cardiogenic pulmonary edema. , 1987, Chest.

[40]  J. Goldberger,et al.  Prognostic factors in acute pulmonary edema. , 1986, Archives of internal medicine.

[41]  J. Mackenzie,et al.  Postoperative enhancement of urinary output in patients with acute renal failure using continuous furosemide therapy. , 1986, Chest.

[42]  M. Winniford,et al.  Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine. , 1986, Circulation.

[43]  J. Katz,et al.  Inspiratory Work with and without Continuous Positive Airway‐Pressure in Patients with Acute Respiratory Failure , 1985, Anesthesiology.

[44]  J. Cohn,et al.  Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. , 1985, Annals of internal medicine.

[45]  L. Paalzow,et al.  Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling. , 1985, The Journal of pharmacology and experimental therapeutics.

[46]  J. Heikkilä,et al.  Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. , 1985, The American journal of cardiology.

[47]  J. Copeland,et al.  Diuresis with continuous infusion of furosemide after cardiac surgery. , 1983, American journal of surgery.

[48]  E. Antman,et al.  Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. , 1983, Circulation.

[49]  S. Taylor,et al.  HAEMODYNAMIC ADVANTAGES OF ISOSORBIDE DINITRATE OVER FRUSEMIDE IN ACUTE HEART-FAILURE FOLLOWING MYOCARDIAL INFARCTION , 1983, The Lancet.

[50]  D. Brater,et al.  The time course of delivery of furosemide into urine: an independent determinant of overall response. , 1982, Kidney international.

[51]  Rybakova Lp Pathophysiology of furosemide ototoxicity. , 1982 .

[52]  D. Brater,et al.  Furosemide in patients with heart failure: Shift in dose‐response curves , 1980, Clinical pharmacology and therapeutics.

[53]  M. Weil,et al.  Hypovolemia and hypotension complicating management of acute cardiogenic pulmonary edema. , 1979, The American journal of cardiology.

[54]  T. Biddle,et al.  Effect of furosemide on hemodynamics and lung water in acute pulmonary edema secondary to myocardial infarction. , 1979, The American journal of cardiology.

[55]  D. Leaman,et al.  The Effects of Morphine on Venous Tone in Patients with Acute Pulmonary Edema , 1976, Circulation.

[56]  B. Pitt,et al.  The Role of Furosemide in the Treatment of Left Ventricular Dysfunction Associated with Acute Myocardial Infarction , 1973, Circulation.

[57]  M. Fulop,et al.  The metabolic and respiratory acidosis of acute pulmonary edema. , 1972, Annals of internal medicine.

[58]  D. Flenley,et al.  Blood-gas exchange after frusemide in acute pulmonary oedema. , 1971, Lancet.

[59]  J. Murtagh,et al.  Acute haemodynamic effects of frusemide in patients with normal and raised left atrial pressures. , 1969, British heart journal.

[60]  A. Rabiner [ON THE TREATMENT OF ACUTE PULMONARY EDEMA]. , 1964, Klinicheskaia meditsina.

[61]  A. L. Simon,et al.  Correlations Between the Chest Film and Hemodynamics in Acute Myocardial Infarction , 1973, Medical services journal, Canada.